Decoding
Decoding
Cancer
Cancer
Nexomic uses frontier AI to decode the hidden biology driving treatment response, resistance, and disease evolution.
Nexomic uses frontier AI to decode the hidden biology driving treatment response, resistance, and disease evolution.
What we do
At Nexomic, we curated large scale patient multiomic data foundation represnetative of tumor biology, with inhouse computational deep profiling approaches and state-of-the-art foundation model to deliver solutions to advance precision oncology from disovery to patients
At Nexomic, we curated a large scale patient multiomic data foundation represnetative of tumor biology, with inhouse computational deep profiling approaches and state-of-the-art foundation model to deliver solutions to advance precision oncology from disovery to patients
The Data Foundation
The Data Foundation
5+ layers
Of multi-omics data with clinically linked outcomes
30+ Countries
Representing data from around the globe with rare subtypes
1 M+
Harmonized features per patient
100M+
Molecular features modeled
DeepOmic®
The Discovery Engine
The Discovery Engine
A Multi-Omic foundation model purpose
built to decode the biology of cancer
A Multi-Omic foundation model purpose
built to decode the biology of cancer
4B
4B
4B
Large scale self-supervised pretraining to be used for downstream tasks applications.
Large scale self-supervised pretraining to be used for downstream tasks applications.
Large scale self-supervised pretraining to be used for downstream tasks applications.
Large scale self-supervised pretraining to be used for downstream tasks applications.
Parameters
Parameters
8000D
8000D
8000D
High-dimensional biological embeddings that capture complex multi-omic disease signals.
High-dimensional biological embeddings that capture complex multi-omic disease signals.
High-dimensional biological embeddings that capture complex multi-omic disease signals.
High-dimensional biological embeddings that capture complex multi-omic disease signals.
Embeddings
Embeddings
1000s
1000s
1000s
Validated across diverse patient datasets to support robust and clinically relevant insights.
Validated across diverse patient datasets to support robust and clinically relevant insights.
Validated across diverse patient datasets to support robust and clinically relevant insights.
Validated across diverse patient datasets to support robust and clinically relevant insights.
Validation
Validation
One
One
One
A unified AI representation of disease biology across omics, patients, and cancer types.
A unified AI representation of disease biology across omics, patients, and cancer types.
A unified AI representation of disease biology across omics, patients, and cancer types.
A unified AI representation of disease biology across omics, patients, and cancer types.
Parameters
Parameters
Solutions
Solutions
#1
Read More
Read More
DISCOVER
A new approach to complex target discovery for resistant patient populations.
Screening Molecular Landscape to Discover New Drug Targets From Real Patient Data
Screening the Molecular Landscape to Discover New Drug Targets From Real Patient Data
Screening Molecular Landscape to Discover New Drug Targets From Real Patient Data
View Project
View Project
Drug Target Discovery
Drug Discovery
Decoding Latent Biology to Understand Heterogeneity and Resistance for Better Clinical Development Design
Decoding Latent Biology to Understand Heterogeneity and Resistance for De-risked Clinical Development Design
Decoding Latent Biology to Understand Heterogeneity and Resistance for Better Clinical Development Design
#1
#2
Read More
DECODE
Read More
Label
A solution for sponsors to de-risk drug development by decoding real-patient multi-omic biology.
A solution to de-risk drug development by decoding real-patient multi-omic biology.
View Project
View Project
De-risking Clinical Development
#1
#3
Read More
oncoREVEAL
Read More
Label
A report to predict drug response from underlying biology, not diagnosis alone.
A report to predict drug response and resistance from underlying biology, not diagnosis alone.
Running Large Scale AI-driven Simulations to Reveal Accurate Patient Response Predictions
Running Large Scale AI-driven Simulations to Reveal Accurate Patient Response Predictions
View Project
View Project
Patient Response Prediction
Delivering on Our Mission
At Nexomic our mission is to decode the biology of heterogeneity and resistance, to deliver the right treatment for every patient
At Nexomic our mission is to decode the biology of heterogeneity and resistance, to deliver the right treatment for every patient
Resources
Contact
Get in touch with us to discuss your project and start building something extraordinary.
Contact
Get in touch with us to discuss your project and start building something extraordinary.
The Greenway, Block C,
112-114 St Stephen's Green,
Dublin 2, D02 TD28
Dublin, Ireland
Decoding
Decoding
Cancer
Cancer
Nexomic uses frontier AI to decode the hidden biology driving treatment response, resistance, and disease evolution.
Nexomic uses frontier AI to decode the hidden biology driving treatment response, resistance, and disease evolution.
What we do
At Nexomic, we curated large scale patient multiomic data foundation represnetative of tumor biology, with inhouse computational deep profiling approaches and state-of-the-art foundation model to deliver solutions to advance precision oncology from disovery to patients
At Nexomic, we curated a large scale patient multiomic data foundation represnetative of tumor biology, with inhouse computational deep profiling approaches and state-of-the-art foundation model to deliver solutions to advance precision oncology from disovery to patients
The Data Foundation
The Data Foundation
5+ layers
Of multi-omics data with clinically linked outcomes
30+ Countries
Representing data from around the globe with rare subtypes
1 M+
Harmonized features per patient
100M+
Molecular features modeled
DeepOmic®
The Discovery Engine
The Discovery Engine
A Multi-Omic foundation model purpose
built to decode the biology of cancer
A Multi-Omic foundation model purpose
built to decode the biology of cancer
4B
4B
4B
Large scale self-supervised pretraining to be used for downstream tasks applications.
Large scale self-supervised pretraining to be used for downstream tasks applications.
Large scale self-supervised pretraining to be used for downstream tasks applications.
Large scale self-supervised pretraining to be used for downstream tasks applications.
Parameters
Parameters
8000D
8000D
8000D
High-dimensional biological embeddings that capture complex multi-omic disease signals.
High-dimensional biological embeddings that capture complex multi-omic disease signals.
High-dimensional biological embeddings that capture complex multi-omic disease signals.
High-dimensional biological embeddings that capture complex multi-omic disease signals.
Embeddings
Embeddings
1000s
1000s
1000s
Validated across diverse patient datasets to support robust and clinically relevant insights.
Validated across diverse patient datasets to support robust and clinically relevant insights.
Validated across diverse patient datasets to support robust and clinically relevant insights.
Validated across diverse patient datasets to support robust and clinically relevant insights.
Validation
Validation
One
One
One
A unified AI representation of disease biology across omics, patients, and cancer types.
A unified AI representation of disease biology across omics, patients, and cancer types.
A unified AI representation of disease biology across omics, patients, and cancer types.
A unified AI representation of disease biology across omics, patients, and cancer types.
Parameters
Parameters
Solutions
Solutions
#1
Read More
Read More
DISCOVER
A new approach to complex target discovery for resistant patient populations.
Screening Molecular Landscape to Discover New Drug Targets From Real Patient Data
Screening the Molecular Landscape to Discover New Drug Targets From Real Patient Data
Screening Molecular Landscape to Discover New Drug Targets From Real Patient Data
View Project
View Project
Drug Target Discovery
Drug Discovery
Decoding Latent Biology to Understand Heterogeneity and Resistance for Better Clinical Development Design
Decoding Latent Biology to Understand Heterogeneity and Resistance for De-risked Clinical Development Design
Decoding Latent Biology to Understand Heterogeneity and Resistance for Better Clinical Development Design
#1
#2
Read More
DECODE
Read More
Label
A solution for sponsors to de-risk drug development by decoding real-patient multi-omic biology.
A solution to de-risk drug development by decoding real-patient multi-omic biology.
View Project
View Project
De-risking Clinical Development
#1
#3
Read More
oncoREVEAL
Read More
Label
A report to predict drug response from underlying biology, not diagnosis alone.
A report to predict drug response and resistance from underlying biology, not diagnosis alone.
Running Large Scale AI-driven Simulations to Reveal Accurate Patient Response Predictions
Running Large Scale AI-driven Simulations to Reveal Accurate Patient Response Predictions
View Project
View Project
Patient Response Prediction
Delivering on Our Mission
At Nexomic our mission is to decode the biology of heterogeneity and resistance, to deliver the right treatment for every patient
At Nexomic our mission is to decode the biology of heterogeneity and resistance, to deliver the right treatment for every patient
Resources
Contact
Get in touch with us to discuss your project and start building something extraordinary.
Contact
Get in touch with us to discuss your project and start building something extraordinary.
The Greenway, Block C,
112-114 St Stephen's Green,
Dublin 2, D02 TD28
Dublin, Ireland
Decoding
Decoding
Cancer
Cancer
Nexomic uses frontier AI to decode the hidden biology driving treatment response, resistance, and disease evolution.
Nexomic uses frontier AI to decode the hidden biology driving treatment response, resistance, and disease evolution.
What we do
At Nexomic, we curated large scale patient multiomic data foundation represnetative of tumor biology, with inhouse computational deep profiling approaches and state-of-the-art foundation model to deliver solutions to advance precision oncology from disovery to patients
At Nexomic, we curated a large scale patient multiomic data foundation represnetative of tumor biology, with inhouse computational deep profiling approaches and state-of-the-art foundation model to deliver solutions to advance precision oncology from disovery to patients
The Data Foundation
The Data Foundation
5+ layers
Of multi-omics data with clinically linked outcomes
30+ Countries
Representing data from around the globe with rare subtypes
1 M+
Harmonized features per patient
100M+
Molecular features modeled
DeepOmic®
The Discovery Engine
The Discovery Engine
A Multi-Omic foundation model purpose
built to decode the biology of cancer
A Multi-Omic foundation model purpose
built to decode the biology of cancer
4B
4B
4B
Large scale self-supervised pretraining to be used for downstream tasks applications.
Large scale self-supervised pretraining to be used for downstream tasks applications.
Large scale self-supervised pretraining to be used for downstream tasks applications.
Large scale self-supervised pretraining to be used for downstream tasks applications.
Parameters
Parameters
8000D
8000D
8000D
High-dimensional biological embeddings that capture complex multi-omic disease signals.
High-dimensional biological embeddings that capture complex multi-omic disease signals.
High-dimensional biological embeddings that capture complex multi-omic disease signals.
High-dimensional biological embeddings that capture complex multi-omic disease signals.
Embeddings
Embeddings
1000s
1000s
1000s
Validated across diverse patient datasets to support robust and clinically relevant insights.
Validated across diverse patient datasets to support robust and clinically relevant insights.
Validated across diverse patient datasets to support robust and clinically relevant insights.
Validated across diverse patient datasets to support robust and clinically relevant insights.
Validation
Validation
One
One
One
A unified AI representation of disease biology across omics, patients, and cancer types.
A unified AI representation of disease biology across omics, patients, and cancer types.
A unified AI representation of disease biology across omics, patients, and cancer types.
A unified AI representation of disease biology across omics, patients, and cancer types.
Parameters
Parameters
Solutions
Solutions
#1
Read More
Read More
DISCOVER
A new approach to complex target discovery for resistant patient populations.
Screening Molecular Landscape to Discover New Drug Targets From Real Patient Data
Screening the Molecular Landscape to Discover New Drug Targets From Real Patient Data
Screening Molecular Landscape to Discover New Drug Targets From Real Patient Data
View Project
View Project
Drug Target Discovery
Drug Discovery
Decoding Latent Biology to Understand Heterogeneity and Resistance for Better Clinical Development Design
Decoding Latent Biology to Understand Heterogeneity and Resistance for De-risked Clinical Development Design
Decoding Latent Biology to Understand Heterogeneity and Resistance for Better Clinical Development Design
#1
#2
Read More
DECODE
Read More
Label
A solution for sponsors to de-risk drug development by decoding real-patient multi-omic biology.
A solution to de-risk drug development by decoding real-patient multi-omic biology.
View Project
View Project
De-risking Clinical Development
#1
#3
Read More
oncoREVEAL
Read More
Label
A report to predict drug response from underlying biology, not diagnosis alone.
A report to predict drug response and resistance from underlying biology, not diagnosis alone.
Running Large Scale AI-driven Simulations to Reveal Accurate Patient Response Predictions
Running Large Scale AI-driven Simulations to Reveal Accurate Patient Response Predictions
View Project
View Project
Patient Response Prediction
Delivering on Our Mission
At Nexomic our mission is to decode the biology of heterogeneity and resistance, to deliver the right treatment for every patient
At Nexomic our mission is to decode the biology of heterogeneity and resistance, to deliver the right treatment for every patient
Resources
Contact
Get in touch with us to discuss your project and start building something extraordinary.
Contact
Get in touch with us to discuss your project and start building something extraordinary.
The Greenway, Block C,
112-114 St Stephen's Green,
Dublin 2, D02 TD28
Dublin, Ireland